2006
DOI: 10.1111/j.1574-6968.2006.00148.x
|View full text |Cite
|
Sign up to set email alerts
|

Cloning and functional characterization of the ambler Class C β-lactamase ofYersinia ruckeri

Abstract: Yersinia ruckeri is a gram-negative pathogen causing enteric redmouth disease in salmonids. Previous studies have reported that Y. ruckeri harbors an ampC gene that is expressed at low level. In this present work, the entire ampC gene of Y. ruckeri was cloned and expressed in Escherichia coli. The AmpC enzyme confers resistance to aminopenicillins and narrow-spectrum cephalosporins, which fit well with the kinetic properties of the purified enzyme. Phylogenetic analysis showed that YRC-1 did not share signific… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 13 publications
0
7
0
Order By: Relevance
“…Similarly, a more recent review suggested that most European isolates are still widely responsive to antibiotherapy [ 72 ]. While a β-lactamase gene has been discovered on the chromosome of Y. ruckeri [ 73 ], there is evidence that this gene is not likely to be expressed at high levels [ 74 ]. In vitro testing has, however, shown that Y. ruckeri readily develops resistance against oxolinic acid, oxytetracycline and potentiated sulphonamide [ 75 ].…”
Section: Control/treatmentmentioning
confidence: 99%
“…Similarly, a more recent review suggested that most European isolates are still widely responsive to antibiotherapy [ 72 ]. While a β-lactamase gene has been discovered on the chromosome of Y. ruckeri [ 73 ], there is evidence that this gene is not likely to be expressed at high levels [ 74 ]. In vitro testing has, however, shown that Y. ruckeri readily develops resistance against oxolinic acid, oxytetracycline and potentiated sulphonamide [ 75 ].…”
Section: Control/treatmentmentioning
confidence: 99%
“…Schiefer et al [15] recently characterized β-lactamases of Y. frederiksenii, Y. bercovieri, Y. aldovae and Y. ruckeri and reported that except for Y. frederiksenii , all expressed only an AmpC β-lactamase. Mammeri et al [16] cloned and sequenced the complete ampC gene of Y. ruckeri and found that it shared low level of identity with the known chromosomal and plasmid AmpC enzymes of closely related members, viz ., Enterobacter cloacae, E. aerogenes and Citrobacter freundii . Much of these data however pertains to strains isolated in Europe.…”
Section: Introductionmentioning
confidence: 99%
“…By screening the susceptibility of Y. ruckeri isolates, they were showed resistance patterns to OT, SXT, AMP, and E. Similar resistance was interpreted by Rodgers, (2001) in oxolinic acid, oxytetracycline, and potentiated sulphonamide. He has attributed it to Y. ruckeri βlactamase gene which is not likely to be expressed at high levels (Stock et al, 2002;Mammeri et al, 2006). Oppositly, Klein et al (1996) did not found resistance patterns among Y. ruckeri isolates, except for a lower sensitivity to OXA.…”
Section: Discussionmentioning
confidence: 99%